Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines. The company was founded in 1981 and is based in Shanghai, China.
Metrics to compare | 603718 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603718PeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.2x | 28.0x | −0.6x | |
PEG Ratio | 0.01 | 0.30 | 0.00 | |
Price/Book | 2.9x | 2.5x | 2.6x | |
Price / LTM Sales | 18.2x | 3.8x | 3.3x | |
Upside (Analyst Target) | - | 24.7% | 38.3% | |
Fair Value Upside | Unlock | 17.2% | 4.5% | Unlock |